Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04007588
Brief Title: A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

First Submitted : July 1, 2019
First Submitted that Met QC Criteria : July 1, 2019
First Posted : July 3, 2019 (Estimate)

Last Update Submitted that Met QC Criteria : November 6, 2019
Last Update Posted : November 8, 2019